The global IoT Software (Platforms) Used in Life Science R&D market size is predicted to grow from US$ 9439 million in 2025 to US$ 22720 million in 2031; it is expected to grow at a CAGR of 15.8% from 2025 to 2031.

In recent years, the life sciences industry has seen remarkable advancements such as the application of IoT (Internet of Things)-based devices which are benefitting patients, manufacturers, doctors, nurses and the entire industry as well. Though the life sciences industry has a conservative rate of adoption of new technologies, it has been among the early adopters of IoT. In life sciences, the real diagnosis, monitoring, preventive measures and treatment in chronic conditions require proactive action and it is feasible today with IoT by embedding sensors and smart devices in our surroundings.

According to our research, the number of global connected IoT devices was about 14 billion, grew by 18% compared to 2021.

1. Key Features:

• Detailed analysis in US$ millions of the world IoT Software (Platforms) Used in Life Science R&D industry.
• Comprehensive overview, market shares, and growth opportunities of IoT Software (Platforms) Used in Life Science R&D market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Software
• Platform

Segmentation by Application:

• Hospital
• Drug Manufacturer
• Laboratories and R&D Institutions

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Company Coverage:

• Microsoft
• Marlabs
• Siemens
• Armis
• Amazon Web Services
• TetraScience
• Tive
• Aizon
• Ordr
• SAS Institute
• Hark Systems
• SAP
• Xenolytix
• Orion Innovation
• IBM
• Igor
• Tata Consultancy Services
• NTT DATA Americas
• HCL Technologies Limited

Key Questions Addressed in this Report: